8 insiders reported 90 Form 4 transactions for CRISPR Therapeutics AG (CRSP) over the past 18 months (most recent 2026-06-01). Recent activity: Patel Naimish (Chief Medical Officer) Buy 10,000 shares, Patel Naimish (Chief Medical Officer) Sell 3,786 shares, KASINGER JAMES R. (General Counsel and Secretary) Buy 6,250 shares, KASINGER JAMES R. (General Counsel and Secretary) Sell 3,182 shares, Prasad Raju (Chief Financial Officer) Buy 6,250 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | Patel Naimish | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-01 | Patel Naimish | Chief Medical Officer | Sell | 3,786 | $210,577 |
| 2026-03-24 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 6,250 | $0 |
| 2026-03-24 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,182 | $148,854 |
| 2026-03-24 | Prasad Raju | Chief Financial Officer | Buy | 6,250 | $0 |
| 2026-03-24 | Prasad Raju | Chief Financial Officer | Sell | 3,708 | $173,460 |
| 2026-03-24 | Kulkarni Samarth | Chief Executive Officer | Buy | 19,687 | $0 |
| 2026-03-24 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,020 | $468,736 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 5,848 | $282,224 |
| 2026-03-17 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,450 | $166,497 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Buy | 10,000 | $0 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Buy | 6,875 | $0 |
| 2026-03-17 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 6,875 | $0 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 4,021 | $194,053 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 750 | $0 |
| 2026-03-17 | Kulkarni Samarth | Chief Executive Officer | Buy | 20,625 | $0 |
| 2026-03-17 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,349 | $499,443 |
| 2026-03-17 | Patel Naimish | Chief Medical Officer | Buy | 8,125 | $0 |
| 2026-03-17 | Patel Naimish | Chief Medical Officer | Sell | 3,150 | $152,019 |
| 2026-03-12 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 5,500 | $0 |
| 2026-03-12 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,800 | $147,840 |
| 2026-03-12 | Kulkarni Samarth | Chief Executive Officer | Buy | 19,250 | $0 |
| 2026-03-12 | Kulkarni Samarth | Chief Executive Officer | Sell | 9,798 | $517,334 |
| 2026-02-20 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 3,825 | $0 |
| 2026-02-20 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 2,112 | $111,049 |
Source: SEC Form 4 filings · as of 2026-06-01